Pain Control Following Total Hip Arthroplasty

NCT05062356 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Chronic Postoperative Pain

Interventions

DRUG: Bupivacaine Hydrochloride 0.25% Injection Solution_#2
DRUG: EPINEPHrine 1:200,000 / Prilocaine HCl 4 % 1.8 ML Cartridge
DRUG: Bupivacaine Hydrochloride 0.5% Injection Solution_#2
DRUG: Ketorolac

Sponsor

St. Mary's Research Center, Canada